The R&D Outsourcing Decision: Environmental Factors And Strategic Considerations
Author
Abstract
Suggested Citation
DOI: 10.1142/S0219877014500023
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Gambardella,Alfonso, 1995. "Science and Innovation," Cambridge Books, Cambridge University Press, number 9780521451185.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Anne W. Fuller, 2018. "Toward a Perspective on R&D Outsourcing: RBV and Firm Performance," International Journal of Innovation and Technology Management (IJITM), World Scientific Publishing Co. Pte. Ltd., vol. 15(05), pages 1-14, October.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Lee Branstetter & Kwon Hyeog Ug, 2004. "The Restructuring Of Japanese Research And Development: The Increasing Impact Of Science On Japanese R&D," Discussion papers 04021, Research Institute of Economy, Trade and Industry (RIETI).
- Scherer, F. M., 2007. "Pharmaceutical Innovation," Working Paper Series rwp07-004, Harvard University, John F. Kennedy School of Government.
- Stephan, Michael, 2013. "Theorien der Industrieevolution," Discussion Papers on Strategy and Innovation 13-03, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
- Lionel Nesta & Pier Paolo Saviotti, 2005.
"Coherence Of The Knowledge Base And The Firm'S Innovative Performance: Evidence From The U.S. Pharmaceutical Industry,"
Journal of Industrial Economics, Wiley Blackwell, vol. 53(1), pages 123-142, March.
- Lionel Nesta & Pier-Paolo Saviotti, 2014. "Coherence of the knowledge base and the firm’s innovative performance: evidence from the U.S. pharmaceutical industry," Post-Print hal-01845543, HAL.
- Silvia Galli, 2006. "Patents and Research Tools in a Schumpeterian Growth Model with Sequential Innovation," Rivista di Politica Economica, SIPI Spa, vol. 96(6), pages 63-104, November-.
- Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
- Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
- Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2013.
"Technological Regimes and Demand Structure in the Evolution of the Pharmaceutical Industry,"
Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 61-94,
Springer.
- Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Journal of Evolutionary Economics, Springer, vol. 22(4), pages 677-709, September.
- Christian Garavaglia & Michele Pezzoni & Luigi Orsenigo & Franco Malerba, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Post-Print halshs-01074513, HAL.
- Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
- Novelli, Elena, 2015. "An examination of the antecedents and implications of patent scope," Research Policy, Elsevier, vol. 44(2), pages 493-507.
- Bastian Rake, 2017.
"Determinants of pharmaceutical innovation: the role of technological opportunities revisited,"
Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
- Bastian Rake, 2012. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," Jena Economics Research Papers 2012-018, Friedrich-Schiller-University Jena.
- Bastian Rake, 2013. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," DRUID Working Papers 13-03, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
- Ashish Arora & Sharon Belenzon & Andrea Patacconi & Jungkyu Suh, 2020.
"The Changing Structure of American Innovation: Some Cautionary Remarks for Economic Growth,"
Innovation Policy and the Economy, University of Chicago Press, vol. 20(1), pages 39-93.
- Ashish Arora & Sharon Belenzon & Andrea Patacconi & Jungkyu Suh, 2019. "The Changing Structure of American Innovation: Some Cautionary Remarks for Economic Growth," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 39-93, National Bureau of Economic Research, Inc.
- Ashish Arora & Sharon Belenzon & Andrea Patacconi & Jungkyu Suh, 2019. "The Changing Structure of American Innovation: Some Cautionary Remarks for Economic Growth," NBER Working Papers 25893, National Bureau of Economic Research, Inc.
- Arnold, Denis G. & Amato, Louis H. & Troyer, Jennifer L. & Stewart, Oscar Jerome, 2022. "Innovation and misconduct in the pharmaceutical industry," Journal of Business Research, Elsevier, vol. 144(C), pages 1052-1063.
- Iain M. Cockburn & Rebecca M. Henderson, 2001. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry," NBER Chapters, in: Innovation Policy and the Economy, Volume 1, pages 1-34, National Bureau of Economic Research, Inc.
- Heide Fier & Andreas Pyka, 2014.
"Against the one-way-street: analyzing knowledge transfer from industry to science,"
The Journal of Technology Transfer, Springer, vol. 39(2), pages 219-246, April.
- Fier, Heide & Pyka, Andreas, 2010. "Against the one-way-street: Analyzing knowledge transfer from industry to science," ZEW Discussion Papers 10-048, ZEW - Leibniz Centre for European Economic Research.
- Ronnie Ramlogan & Davide Consoli, 2014. "Dynamics of collaborative research medicine: the case of glaucoma," The Journal of Technology Transfer, Springer, vol. 39(4), pages 544-566, August.
- Jackie Krafft & Francesco Quatraro & Pier Saviotti, 2014.
"Knowledge characteristics and the dynamics of technological alliances in pharmaceuticals: empirical evidence from Europe, US and Japan,"
Journal of Evolutionary Economics, Springer, vol. 24(3), pages 587-622, July.
- Krafft Jackie & Quatraro Francesco & Saviotti Pier Paolo, 2011. "Knowledge characteristics and the dynamics of technological alliances in Pharmaceuticals: Empirical evidence from Europe, US and Japan," Department of Economics and Statistics Cognetti de Martiis LEI & BRICK - Laboratory of Economics of Innovation "Franco Momigliano", Bureau of Research in Innovation, Complexity and Knowledge, Collegio 201113, University of Turin.
- Jackie Krafft & Francesco Quatraro & Pier-Paolo Saviotti, 2014. "Knowledge characteristics and the dynamics of technological alliances in Pharmaceuticals: Empirical evidence from Europe, US and Japan," Post-Print hal-02632021, HAL.
- Jackie Krafft & Francesco Quatraro & Pier-Paolo Saviotti, 2014. "Knowledge characteristics and the dynamics of technological alliances in Pharmaceuticals: Empirical evidence from Europe, US and Japan," Post-Print hal-01070561, HAL.
- Toole, Andrew A, 2007. "Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry?," Journal of Law and Economics, University of Chicago Press, vol. 50(1), pages 81-104, February.
- Alfonso Gambardella & Davide Ticchi, 1999. "Technology, Entrepreneurship and Inequality: an Interpretative Model," LEM Papers Series 1999/11, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
- Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014.
"Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data,"
Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
- Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Post-Print halshs-01074524, HAL.
More about this item
Keywords
R&D; outsourcing; innovation;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wsi:ijitmx:v:11:y:2014:i:02:n:s0219877014500023. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Tai Tone Lim (email available below). General contact details of provider: http://www.worldscinet.com/ijitm/ijitm.shtml .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.